-
The company completed its upsized IPO last week and traded up to 1.3x book. -
The take-up rate will depend on the price discount and market segment.
-
The conglomerate’s insurance subsidiaries will have to make do without some of their prior strategic advantages.
-
The facility is a nudge towards a structural change, not a full-out assault.
-
Business hates uncertainty and geopolitical tensions are off the charts.
-
The investment recovery will be welcome but Chinese tariffs will contribute to loss-cost inflation.
-
Insurance Insider US examines potential tariffs’ impact on the PE-backed brokers amid the jammed conveyor belt.
-
The insurer also pointed to accelerating growth, M&A to come, and a sub-30% ER.
-
After a period of business building, MGAs will likely spend more time optimizing.
-
It makes sense for Next to secure a sale as an exit strategy in an increasingly challenging funding environment.
-
Cue a feeding frenzy from suitors and a frenzy of speculation from the market.
-
The non-peak peril is not secondary anymore.
